Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
18.19
-0.61 (-3.24%)
At close: May 29, 2026, 4:00 PM EDT
18.66
+0.47 (2.58%)
After-hours: May 29, 2026, 5:12 PM EDT
Seaport Therapeutics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Seaport Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $35.5. The average 1-year stock price forecast is 95.16% higher than the current stock price, while the lowest is $30 (+64.93%) and the highest is $42 (+130.90%).
Price Target: $35.5 (+95.16%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Seaport Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 |
|---|---|
| Strong Buy | 3 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $35 | Buy | Initiates | $35 | +92.41% | May 26, 2026 |
| Citi | Citi | Buy Initiates $35 | Buy | Initiates | $35 | +92.41% | May 26, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $30 | Buy | Initiates | $30 | +64.93% | May 26, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $42 | Buy | Initiates | $42 | +130.90% | May 26, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.